May 19, 2015 Dear Public Health Official: The U.S. National Institutes of Health recently added post-finasteride syndrome (PFS) to its Genetic and Rare Diseases Information Center, noting that: “Studies are underway to understand the safety profile of 5-alpha reductase inhibitor drugs with respect to adverse events…and their permanency.” This federal listing of PFS comes in […]
Tag Archives: Propecia
2013 में PFSFoundation.org गुलाब पर राष्ट्रों की संख्या 29% बढ़ी
SOMERSET, N.J., Jan. 6, 2014 – The number of nations that logged onto the Post-Finasteride Syndrome Foundation website rose 29 percent in 2013, according to Google Analytics. In all, users in 120 countries outside the United States—or 61 percent of the world (as defined by the 195 nations recognized by the U.S. Department of State)—accessed […]
डॉक्टरों ने रिसर्च स्टडीज के लिए पीएफएस मरीजों की भर्ती की
SOMERSET, N.J., June 16, 2014 – Post-finasteride syndrome research initiatives at two major U.S. medical institutions, Brigham and Women’s Hospital (a Harvard Medical School Teaching Affiliate) in Boston, Mass., and Baylor College of Medicine in Houston, Texas, are currently recruiting patients for their respective studies on the condition. If you are interested in participating, or […]
स्टेरॉयड और तंत्रिका तंत्र पर अंतर्राष्ट्रीय बैठक में चिकित्सा शोधकर्ताओं के लिए पोस्ट-फ़ाइस्टरसाइड सिंड्रोम फाउंडेशन प्रायोजक पीएफएस राउंडटेबल
SOMERSET, N.J., Nov. 5, 2012 – The Post-Finasteride Syndrome Foundation is sponsoring a round-table discussion on PFS at the University of Milan’s 7th International Meeting on Steroids and the Nervous System conference in Torino, Italy, Feb. 19, 2013. Titled “Effects of Finasteride Treatment on the Nervous System,” the event is being organized by Roberto Melcangi, […]
फाउंडेशन ने पोस्ट-फ़ाइनस्टराइड सिंड्रोम में फंड रिसर्च के लिए वेबसाइट लॉन्च की
The Post-Finasteride Syndrome Foundation today launched its website, PFSFoundation.org. The Post-Finasteride Syndrome Foundation is dedicated to helping fund research on the characterization, underlying biologic mechanisms and treatments of the post-finasteride syndrome (PFS).